About Us

GlycoSyn has been operating internationally for nearly a decade. We deliver development and manufacturing services involving active pharmaceutical ingredients (API’s) ranging from conventional small molecules to dendrimers and complex oligosaccharides.

GlycoSyn’s world-class expertise in carbohydrate chemistry and its GMP manufacturing facility are in New Zealand, near the capital city of Wellington. From here, the company partners with clients in all corners of the globe.  Respected global surveys, such as the World Bank’s Doing Business Project, consistently rank New Zealand as one of the easiest countries in the world in which to do business. It also has one of the best reputations for protecting intellectual property. Find out more about biotechnology in New Zealand.

The United States is an important market for GlycoSyn and we have dedicated business development/customer service staff on the ground there. Find out more about one of our
US representatives.

GlycoSyn provides synthetic route evaluation and development, process development, kilogram scale non-GMP and GMP manufacture of a variety of investigational new drugs under contract to global pharmaceutical companies. GlycoSyn’s expertise is in solving complex problems requiring carbohydrate chemistry and multi-step chemical synthesis.

GlycoSyn recognises the value and commercial sensitivities around confidentiality and ownership of intellectual property. This allows us to offer services under contract without claim to any discovery, improvement or gain in efficiency, realised during that contract. In short, our clients own and retain 100 per cent of their intellectual property.